PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
22-Sep-2021 Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry Velocity Clinical Research
20-Sep-2021 Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with Erdafitinib in Combination with Cetrelimab, a PD-1 Inhibitor The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2021 Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference SMi Group
20-Sep-2021 Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation Novartis
16-Sep-2021 Pharmapack Report 2021: US leads on drug device innovation but trails Europe on sustainability Pharmapack Europe
15-Sep-2021 Perception Neuroscience Initiates Phase 2a Study of PCN-101 (R-ketamine) for Treatment Resistant Depression Perception Neuroscience
10-Sep-2021 PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia PureTech Health plc
09-Sep-2021 HUTCHMED and AstraZeneca Initiate SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China HUTCHMED and AstraZeneca
09-Sep-2021 ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly ProQR
09-Sep-2021 USPTO Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies ONK Therapeutics
09-Sep-2021 Nanoform technology delivers successful results for Herantis CDNF drug candidate Nanoform
09-Sep-2021 Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease Freeline
09-Sep-2021 Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day Moderna
09-Sep-2021 Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis Centessa Pharmaceuticals
09-Sep-2021 Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline Amolyt Pharma
09-Sep-2021 Anticancer Bioscience Announces its First Granted US Patent for Synthetic Lethal Approach to Identifying Novel Cancer Treatments Anticancer Bioscience
08-Sep-2021 NICE backs Janssen’s Erleada®▼ (apalutamide) for Hormone-Sensitive Metastatic and Hormone-Relapsed Non-Metastatic Prostate Cancer Janssen
07-Sep-2021 HUTCHMED Highlights Clinical Data to be Presented at the Upcoming 2021 ESMO Virtual Conference HUTCHMED
06-Sep-2021 New tezepelumab data show 86% reduction in exacerbations in patients with severe asthma and comorbid nasal polyps AstraZeneca
01-Sep-2021 Bimuno surpasses 100 scientific publications landmark Clasado Biosciences